EGFR and breast carcinoma: In the current study, a new liposome, 111In-EGF-LP-Dox, was designed for chemo-radionuclide therapy of EGFR-positive cancer and the use of US-induced cavitation to enhance its delivery to breast cancer tumour models was investigated.